These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1715540)
21. Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings. Persico AM; Altamura C; Calia E; Puglisi-Allegra S; Ventura R; Lucchese F; Keller F Cereb Cortex; 2000 Feb; 10(2):181-91. PubMed ID: 10667986 [TBL] [Abstract][Full Text] [Related]
22. Effects of idebenone on metabolism of monoamines and cyclic AMP formation in rats. Nagai Y; Narumi S; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y Arch Gerontol Geriatr; 1989 May; 8(3):273-89. PubMed ID: 2475075 [TBL] [Abstract][Full Text] [Related]
23. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats. Mattila J; Buñag RD J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259 [TBL] [Abstract][Full Text] [Related]
24. Behavioral syndrome induced by allylnitrile, crotononitrile or 2-pentenenitrile in rats. Tanii H; Hayashi M; Hashimoto K Neuropharmacology; 1991 Aug; 30(8):887-92. PubMed ID: 1723510 [TBL] [Abstract][Full Text] [Related]
25. TRH-induced tachyphylaxis: present in the smooth muscle but not in the cardiorespiratory effects. Järvinen A; Paakkari I Pharmacol Toxicol; 1991 Apr; 68(4):270-5. PubMed ID: 1907737 [TBL] [Abstract][Full Text] [Related]
26. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests. Eide PK; Hole K; Berge OG; Broch OJ Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956 [TBL] [Abstract][Full Text] [Related]
27. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo. O'Connell MT; Portas CM; Sarna GS; Curzon G Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108 [TBL] [Abstract][Full Text] [Related]
28. Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine. Schaefer CF; Brackett DJ; Biber B; Lerner MR; Holaday JW; Wilson MF; Fagraeus L Regul Pept; 1989 Mar; 24(3):269-82. PubMed ID: 2496439 [TBL] [Abstract][Full Text] [Related]
29. The cardiovascular effects of thyrotropin-releasing hormone (TRH) are attenuated by cimetidine in rats. Nurminen ML; Paakkari I; Jrvinen A; Vonhof S Pharmacol Toxicol; 1991 Nov; 69(5):322-6. PubMed ID: 1803344 [TBL] [Abstract][Full Text] [Related]
30. Serotonin and thyrotropin-releasing hormone do not augment their effects on gastric motility on their microinjection into the nucleus raphe obscurus of the rat. Krowicki ZK; Hornby PJ J Pharmacol Exp Ther; 1995 Apr; 273(1):499-508. PubMed ID: 7714805 [TBL] [Abstract][Full Text] [Related]
31. Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse. Colado MI; Ormazabal MJ; Goicoechea C; Lopez F; Alfaro MJ; Martin MI Eur J Pharmacol; 1994 Feb; 252(3):291-7. PubMed ID: 7512926 [TBL] [Abstract][Full Text] [Related]
32. Differential effect of fluorinated analogs of TRH on the cardiovascular system and prolactin release. Feuerstein G; Lozovsky D; Cohen LA; Labroo VM; Kirk KL; Kopin IJ; Faden AI Neuropeptides; 1984 Jun; 4(4):303-10. PubMed ID: 6433221 [TBL] [Abstract][Full Text] [Related]
33. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals. Helke CJ; Phillips ET J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544 [TBL] [Abstract][Full Text] [Related]
34. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat. Tsay BL; Lin MT Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757 [TBL] [Abstract][Full Text] [Related]
35. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse. Singleton C; Marsden CA Psychopharmacology (Berl); 1981; 74(2):173-6. PubMed ID: 6168003 [TBL] [Abstract][Full Text] [Related]
36. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine. Collu R; Clermont MJ; Ducharme JR Eur J Pharmacol; 1976 May; 37(1):133-40. PubMed ID: 819277 [TBL] [Abstract][Full Text] [Related]
37. Effects of TRH and TRH analogues on the central regulation of breathing in the rat. Hedner J; Hedner T; Wessberg P; Lundberg D; Jonason J Acta Physiol Scand; 1983 Mar; 117(3):427-37. PubMed ID: 6410685 [TBL] [Abstract][Full Text] [Related]
38. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems. Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907 [TBL] [Abstract][Full Text] [Related]
40. Increase in levels and ex vivo release of thyrotrophin-releasing hormone (TRH) in specific regions of the CNS of the rat by chronic treatment with antidepressants. Lighton C; Bennett GW; Marsden CA Neuropharmacology; 1985 May; 24(5):401-6. PubMed ID: 2410804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]